By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Spark Therapeutics 

3737 Market Street
Suite 1300
Philadelphia  Pennsylvania  10104  U.S.A.
Phone: 888-772-7560 Fax: n/a


SEARCH JOBS

Spark Therapeutics is developing curative, one-time gene therapy products with the potential to transform the lives of patients and re-imagine the treatment of debilitating diseases. Spark's lead gene therapy candidate, for RPE65-related blindness, is currently in Phase 3 clinical trials with the potential to be the first approved gene therapy in the United States, and the first approved treatment to address the significant unmet needs of patients living with blindness due to inherited retinal dystrophies.

Additionally, the company has clinical and preclinical programs in other inherited retinal dystrophies and hematological disorders, and a proprietary manufacturing platform that has successfully supported human gene therapy trials across diverse therapeutic areas and routes of administration. Spark’s founding team includes scientists who led the movement to develop gene therapy as a new treatment paradigm, establishing clinical proof of concept in the eye and liver and contributing key insights to the field that have resulted in a resurgence of industry interest in gene-based medicines.

Spark is based in Philadelphia, PA and was spun out of The Children's Hospital of Philadelphia in October 2013. In May 2014, Spark announced the completion of a $72.8 million Series B financing led by Sofinnova Ventures, bringing the company's total funding raised to $82.8 million to-date. To learn more about Spark visit www.sparktx.com.


Key Statistics


Email: info@sparktx.com
Ownership: Private

Web Site: Spark Therapeutics
Employees: n/a
Symbol: 
 



Industry
Biotechnology






Company News
Spark Therapeutics Appoints Rare Disease Pioneer Dr. Rogerio Vivaldi As Chief Commercial Officer 12/16/2014 8:20:40 AM
Spark Therapeutics Strikes $280 Million Hemophilia B Pact With Pfizer (PFE) 12/8/2014 5:48:57 AM
Spark Therapeutics Appoints Former Chief Of U.S. FDA's Gene Therapy Branch As Its Head Of Regulatory Affairs 11/25/2014 9:28:00 AM
Spark Therapeutics Snags FDA Breakthrough Therapy Designation For Lead Product 11/6/2014 9:16:48 AM
Top 30 Life Science Startups To Watch In The U.S. 10/23/2014 4:27:21 AM
Spark Therapeutics Appoints Industry Leaders Lars Ekman And Vin Milano To Board Of Directors 6/16/2014 8:20:42 AM
Children's Hospital of Philadelphia Gene-Therapy Spinout Spark Therapeutics Hauls In $72.8 Million 5/28/2014 6:30:06 AM
Spark Therapeutics To Present At The American Society Of Gene & Cell Therapy 2014 Annual Meeting 5/19/2014 10:28:18 AM
Spark Therapeutics Establishes Permanent Headquarters In West Philadelphia 5/13/2014 12:26:27 PM
Spark Therapeutics Announces Five Strategic New Hires 4/25/2014 12:59:23 PM
12
//-->